Exploratory, Phase II Controlled Trial of Shiunko Ointment Local Application Twice a Day for 4 Weeks in Ethiopian Patients with Localized Cutaneous Leishmaniasis

Figure 5

Frequencies (number) of adverse events observed during (a) treatment and (b) follow-up periods in Shiunko and placebo groups.

(a)

(b)